Preparation to raise funds through preferential issue, shares will be in discussion on Monday

The shares of Sudarshan Pharma Industries Limited, which is involved in the business of specialty chemicals, will be the center of discussion in the market on Monday. The company has announced to raise funds up to ₹188.34 crore through preferential issue. The impact of this news can be seen on the company’s shares. Let us tell you that this small-cap share is currently trading at less than ₹ 50.

fund raising plan

Sudarshan Pharma plans to issue 4,30,00,000 shares with the aim of expanding its business, improving operational efficiencies and ensuring long-term financial sustainability.

• Total fund raising target: ₹188.34 crore
• Promoters’ stake: 57.39%
• Public Shareholding: 42.61%

Multibagger Share: Gave great returns to investors

This small-cap stock, currently priced at ₹48, is known to deliver multibagger returns.

• Last 1 month: 14% return
• Last 6 months: 450% returns
• Last 1 year: 525% return

52-week high: ₹53.50
52-week low: ₹5.82

The stock has outperformed the Frontline index and given returns of more than 8% in 2025.

IPO and Stock Split

• IPO launch: 9 March 2023
• Shares in one lot: 1600
• Minimum investment amount: ₹1,16,800
• Stock Split: In the ratio of 1:10

Company Business and Exports

Sudarshan Pharma Industries operates in the field of specialty chemicals for the pharmaceutical and chemical industries. The company exports its products to countries like UK, Australia, Uzbekistan, Syria, Oman, and Taiwan.

What to do for investors?

1. Growth Potential of the Stock: Based on recent returns, this stock looks attractive for long-term investment.
2. Effect of fund raising: Preferential issue can promote expansion and sustainability of the company.
3. Risk Management: Small-cap stocks are more volatile. Investors should keep their portfolio balanced.